GLYCOBIOSCIENCES, INC. v. INNOCUTIS HOLDINGS, LLC
1:12-cv-01901
Overview
Parties
Defendant
FIDIA FARMACEUTICI S.P.A. NPE (Individual / Inventor)
Represented By
2 Attorneys ListedBIRCH STEWART KOLASCH & BIRCH, LLP
8110 Gatehouse Road, Suite 100 East
Counter Claimant
FIDIA FARMACEUTICI S.P.A. NPE (Individual / Inventor)
Represented By
2 Attorneys ListedBIRCH STEWART KOLASCH & BIRCH, LLP
8110 Gatehouse Road, Suite 100 East
INNOCUTIS HOLDINGS, LLC. NPE (Patent Assertion Entity)
Represented By
3 Attorneys ListedBIRCH STEWART KOLASCH & BIRCH, LLP
8110 Gatehouse Road, Suite 100 East
DARA BIOSCIENCES, INC. Operating Company
Represented By
3 Attorneys ListedBIRCH STEWART KOLASCH & BIRCH, LLP
8110 Gatehouse Road, Suite 100 East
Counter Defendant
Court & Judges
Court
District Court, District of Columbia (dcd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇨🇦 Canada | Canada Counterpart | View Official Patent → | |
| 🇨🇦 Canada | Canada Counterpart | View Official Patent → | |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US4767463
Glycosaminoglycan and cationic polymer combinations
|
Filed: 1987-04-15
Issued: 1988-08-30
|
Expired (Term Ended)
Expires: 2007-04-15
|
|
|
US4240450
Composition and process for the treatment of keratin materials with polymers
|
Filed: 1978-03-14
Issued: 1980-12-23
|
Expired (Term Ended)
Expires: 1998-03-14
|
|
|
US6335034
Topical drug preparations
|
Filed: 2000-03-29
Issued: 2002-01-01
|
Expired (Term Ended)
Expires: 2020-03-29
|
|
|
US6120804
Topical drug preparations
|
Filed: 1999-04-08
Issued: 2000-09-19
|
Expired (Term Ended)
Expires: 2019-04-08
|
|
|
US6723345
Topical drug preparations
|
Filed: 2001-11-07
Issued: 2004-04-20
|
Expired (Term Ended)
Expires: 2021-11-07
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
98
Dispositive
38
Granted
1
Denied
0
Pending / Review
71
Motions by Category
Key Dispositive Motions & Rulings